课题基金 / 基金详情

Clinical and Translational Science Award (UL1)

Clinical and Translational Science Award (UL1)
临床和转化科学奖 (UL1)
批准号:
8089754
负责人:
HARRY SHAMOON
金额:
$88.7万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-23 至 2011-07-22

项目摘要

项目成果

HARRY SHAMOON的其他基金

相似基金

相关文献

中文摘要
翻译
修订后的申请(A2)响应了CTSA关于建立和维持学术社区的倡议 临床和转化性研究的伙伴关系/为了实现这一目标,我们创建了临床和转化研究研究所 翻译研究(卢旺达问题国际法庭)建立在成功的相互依存的方案基础上,包括儿科和成人方案 患者研究设施、核心实验室、K30临床研究培训计划扩大到包括博士学位 临床研究,以及NCRR K12职业发展奖。卢旺达问题国际法庭由 阿尔伯特·爱因斯坦医学院、耶希瓦大学和蒙特菲奥里医学中心,并积极参与 构成布朗克斯区140万种族多样性人口的社区。卢旺达问题国际法庭还与 区域和附属机构,包括纽约市卫生部、北布朗克斯卫生网、 临床主任网络、雷曼学院和新罗谢尔护理学院扩大研究和 布朗克斯的培训机会。CTSA在过去两年的开发过程中使用了 来自多个学科的广泛教职员工(包括医学、牙科、护理、流行病学、社会学 工作和生物医学)通过这些变革性的伙伴关系。与发展爱因斯坦的 2007年战略研究计划,我们1)评估了机构内部的障碍,以培养内在的协同效应; 2)启动了机构范围内建立跨学科研究联系的进程;3)制定了 整合支持临床/转化性研究的现有基础设施;4)投资于新基础设施- 支持CTSA任务的实体设施和计划;5)统一IRB审查流程;以及6) 强调培训和培养一批年轻的调查人员。这个新研究所的合作伙伴共同 提供有形资源,包括一个新的200,000 NSF遗传和转化医学中心,30,000 为卢旺达问题国际法庭方案和调查人员、联合临床研究捐赠基金和配对基金提供空间 R taondsuCppaorretetraDnesvlaetliopnmaletnet;chbn)olDoegsieigsna,nBdiosscthao titilasrisc.s,TahnedICRTeRsecormchpoEntets Arres:非统)rcRe;sce)arPchartEicpuacantioan,dTrariiniincga,L 互动资源,包括成人和儿科研究单位;d)社区参与和 协作;e)监管知识和支持;f)生物医学信息学;g)开发;新颖 临床/翻译方法学“孵化器”(干细胞研究、生物统计学方法学、 行为/社会科学研究和表观基因组学研究);h)翻译技术和资源 (MS分析核心,生物仓库,生物标记分析核心,翻译遗传学和基因组学资源,以及 细胞治疗实验室);i)试点和合作项目;j)其他关键要素(共享设施 和核心,以及跨学科研究计划)。卢旺达问题国际法庭的使命是加强临床和 翻译研究通过促进多学科合作,解决研究中的翻译“障碍”, 提供基础设施和协作支持,并加强培训、教育和职业发展。
英文摘要
This revised application (A2) responds to the CTSA initiative to establish and sustain an academic-community partnership for clinical and translational research/To achieve this goal, we created the Institute for Clinical and Translational Research (ICTR) founded on successful inter-dependent programs, including pediatric and adult patient research facilities, core laboratories, a K30 clinical research training program expanded to include a PhD n clinical investigation, and an NCRR K12 award for Career Development. The ICTR is jointly supported by the Albert Einstein College of Medicine, Yeshiva University and Montefiore Medical Center, and actively engages the communities comprising the 1.4 million ethnically diverse population of the Bronx. The ICTR also collaborates with regional and affiliated institutions, including the NYC Department of Health, the North Bronx Health Network, the Clinical Directors Network, Lehman College, and New Rochelle College of Nursing to expand research and training opportunities across the Bronx. The CTSA development process over the past 2 years has engaged a broad array of faculty from a number of disciplines (including medicine, dentistry, nursing, epidemiology, social work, and biomedical sciences) through these transformative partnerships. In parallel with developing Einstein's 2007 Strategic Research Plan, we 1) assessed the barriers within our institutions to cultivate inherent synergies; 2) initiated an Institution-wide process of forging interdisciplinary research linkages; 3) developed plans to consolidate existing infrastructure that supports clinical/translational research; 4) invested in new infrastructure- both physical facilities and programs-that support the CTSA mission; 5) unified the IRB review process; and 6) emphasized the training and nurturing a cohort of young investigators. The partners in this new Institute jointly provide tangible resources, including a new 200,000 nsf Center for Genetic and Translational Medicine, 30,000 nsf of space for ICTR programs and investigators, a joint Clinical ResearchEndowment fund, and matching funds r taondsuCppaorretetraDnesvlaetliopnmaletnet;chbn)olDoegsieigsna, nBdiosscthaotilsatrisc.s,TahnedICRTeRsecaormchpoEntehnicts aRres: oau)rcRe;sce)arPchartEicdipuacantioan,dTrCaliiniincga,l Interaction Resources, including Adult and Pediatric Research Units; d) Community Engagement and Collaboration; e) Regulatory Knowledge and Support; f) Biomedical Informatics; g) Development; Novel Clinical/Translational Methodology "incubators" (Stem Cell Research, Biostatistical Methodologies, Behavioral/Social Science Research, and Epigenomics Research); h) Translational Technologies and Resources (MS Analytic Core, Biorepository, Biomarker Assay Core, Translational Genetics and Genomics Resource, and Cellular Therapeutics Laboratory); i) Pilot & Collaborative Projects; and j) Other key elements (shared facilities and cores, and transdisciplinary research programs). The mission of the ICTR is to enhance clinical and translational research by promoting multidisciplinary collaboration, addressing translational 'blocks' in research, providing infrastructure and collaborative support, and enhancing training, education, and career development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical and Translational Science Award
Clinical and Translational Science Award
Clinical and Translational Science Award
Clinical and Translational Science Award
海外基金